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Abstract 
Early in the pandemic, as scientific reports and preliminary research on both clinical and public health aspects 
of COVID-19 were rapidly generated, we recognised the need for a dynamic, interactive tool that could capture 
and collate emerging evidence sources to inform research and decision-making efforts. In particular, we observed 
that numerous similar research efforts across the globe were happening in parallel - prompting an urgent need to 
connect research teams with each other and maximize research efficiency. Our colleagues in China provided daily 
translations of emerging evidence to aid networking between research groups working across the world. Here we 
describe how the meta-evidence project met daily and ongoing challenges and what was learned as a result. We 
describe the benefit of finding ways to instead work with better resourced teams and promote collective and open 
efforts to synthesise the evidence, which in the end, outweighed the considerable costs. 
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Background  
On 11 March 2020, the WHO declared the SARS-
CoV-2 outbreak a global pandemic and as of 29 April 
2021, there have been 147,443,848 confirmed cases 
and 3,117,542 deaths (European Centre for Disease 
Prevention and Control figures). As the global spread 
of COVID-19 continues to grow, disease control and 
prevention will be challenging, and this requires collab-
orative solutions and cooperative spirit from all groups. 
There has been a tremendous response from the scien-
tific community to generate timely and responsive re-
search, which has translated to an exponential growth 
in COVID-19 related research literature (Figure 1). It 
is estimated that there are at least 129,570 COVID-
19-related publications to date (1). While this wealth 
of research is a potential boon for addressing both 
multi-dimensional aspects of the pandemic, from clinic 
to social, the reliability and rigor of these papers is 
quite variable. In fact, a study conducted two months 
after the pandemic was declared found that most of the 
papers being published had a shorter time to publica-
tion and were of lower methodological quality than 
matched control studies on other clinical studies from 
the same journals (2). Moreover, many papers are quite 
similar in topic - for example, as of the 30 April 2021, 
there are approximately 5,590 health systematic re-
views on COVID-19 (L.OVE platform, Epistemonikos 
foundation) with many on the same topic. One re-
search team identified 25 systematic reviews reporting 
on 17 primary studies, all answering the same question 
of interest (3). This overlap and duplications signal that 
much of the race to research COVID-19 has resulted 
in “research waste” (4) and that research efforts could 
be combined to produce more rigorous and/or compre-
hensive insights. 
 
The role of evidence synthesis and 
semi-automated text-mining bots 
The rapidly evolving landscape of knowledge with re-
spect to viral biology, disease presentation, clinical out-
comes, social and economic impacts, and potential 
treatments and prevention required and continues to 
require a rapid, dynamic approach to synthesize 
emerging information to inform on-the-ground deci-
sions. Evidence syntheses (including systematic re-
views, evidence and gap maps, scoping reviews, and 
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Fig. 1. This automatically generated report is based on Dimensions data and was retrieved from https://reports.dimen-
sions.ai/covid-19/ on 28 May 2021 to depict weekly new publications on COVID-19, by type of publication.
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meta-analysis) are critical tools for collating and syn-
thesising insights from the broad evidence base using 
transparent and reproducible methods. 
The information-poor and high-risk context of the 
COVID-19 pandemic requires rapid approaches for ev-
idence synthesis (5) to provide and communicate reli-
able summaries of emerging evidence and inform and 
update clinical guidelines and public health recommen-
dations.  
Over this past year, while many syntheses (including 
systematic reviews) have been conducted, the pace of 
knowledge production means that these reviews be-
come rapidly outdated and lose both relevancy and ac-
curacy (5).  Dr Gabriel Rada, co-founder of 
Epistemonikos, describes reviewers missing relevant 
studies and outlines an unpublished analysis which 
found 95% of reviews about drug treatments in 
COVID-19 were out of date due to rapid publication 
of new clinical trial data (6). In addition, the rapid pro-
duction of reviews to keep up with the pace of publi-
cations has resulted in the production of reviews with 
lower methodological quality ˗ thus reliability ˗ which 
is further exacerbated by the acceleration of the publi-
cation process, often skipping or rushing the peer re-
view process (7). 
We developed the COVID-19 twitter bot (www.twit-
ter.com/@COVID_Evidence) to harness, in real-time, 
the emerge of COVID-19 research. The bot, which has 
now been active for over a year, produces a diverse 
range of real-time research and commissioned reports 
directly onto a twitter feed using the RSS sources from 
a range of science and medical databases. The 
COVID-19 Twitter Bot was one of the first sources to 
emerge with a focus on real-time acquisition and col-
lation of research findings about COVID-19.  
This bot created by an evidence synthesis expert and a 
consultant kidney physician was capable of persistently 
posting relevant content without requiring sustained 
human involvement past its creation.  
 
Building a collaborative “living” atlas 
of COVID-19 research 
Building and launching the COVID-19 Twitter Bot al-
lowed our group to collate significant bibliographies of 
emerging research on COVID-19. Given growing limi-
tations on resources under economic impacts from the 
pandemic, we saw a need for a living atlas that could 
aid networking between research groups working across 
the world. Having this knowledge could help future re-
search efforts be more targeted towards existing gaps, 
reduce inefficiency and duplication, and foster collabo-
ration. We built an interactive, visual database of 
COVID-19 research that featured an interactive geo-
graphical map that reflected emerging evidence sources 
(e.g. articles and resources) collated from the auto-
mated aggregating Twitter feed, and supplemented by 
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sources such as the WHO database (Figure 2). We 
named this endeavor the meta-evidence project. The in-
teractive geographic map was powered by EviAtlas, an 
open access platform for visualizing synthesis data (8).  
In particular, at the time we were building the map, the 
literature being captured by the bot was primarily in 
English and limited to geographies with users present 
on Twitter. Thus, there were significant gaps in cover-
age, particularly research emerging from China, who 
at that stage, had more lived experience of the virus 
and disease than the rest of the world. Dr Howard 
White, CEO of the Campbell Collaboration collabo-
rated with Professor Kehu Yang, Director of Lanzhou 
University’s Evidence Based Medicine Centre in China 
to compile and translate evidence from sources in Chi-
nese to expand the map’s coverage. This work was 
made possible given the generous pro bono effort from 
Professor Yang and a team of seven researchers.  
 
Challenges  
The meta-evidence project responded rapidly to the global 
spread of COVID-19 at a time when rumours and con-
jecture were also spreading through social and mainstream 
media, this pace was met with various and significant chal-
lenges.  
First, the “living” atlas was dependent on the resources of 
volunteers who were building the atlas in their spare time. 
This effort was borne from a tweet asking for help and 
pulled in medical professionals, data scientists and evi-
dence synthesis experts from all disciplines, globally, and 
highlighted a true sense of community contribution. How-
ever, this meant that volunteers were working on the map 
in their “spare” time, typically after long workdays and dur-
ing a time when spare time was already being eaten due 
to closures of schools and daycare facilities. Also, we 
learned of much-better resourced groups like the EPPI-
Centre, COVID-NMA and the Norwegian Institute of 
Public Health who were, and still are working hard to 
avoid out-of-date research by producing living maps of Ev-
idence.  
Second, we noted that publishers had relaxed some of 
their strict guidelines. This meant that many studies had 
been widely published without sufficient peer review. We 
felt that it is important to incorporate an assessment of 
quality so that readers can understand which studies are 
likely to be reliable. However, this was something we sim-
ply did not have the people power to do.  
Third, pandemics such as COVID-19 require expedited 
data and research findings to help understand the situa-
tion and potential treatment and vaccines. Rarely though 
does a pandemic affect all sectors of society and the re-
search community on such a global scale. Due to the im-
pact of COVID-19 across all sectors of society, the 
research was and still is being produced in large volumes 
across all disciplines which made it difficult to categorise. 
This difficultly meant that it was difficult to continue map-
Fig. 2. A screenshot of the interactive geographical map built using EviAtlas (8).
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ping the research on the atlas in a meaningful and useful 
way for individual disciplines.  
Finally, after conversations with key people in leading or-
ganisations including Cochrane, Campbell, EPPI-Centre, 
Evidence Aid, Evidence synthesis Ireland, it became clear 
that this work had been overtaken by other teams with 
dedicated resources. One of the most influential conver-
sations had in this time was with Professor Mike Clarke, 
founder of Evidence Aid and expert in the human re-
sponse to humanitarian disasters. After speaking with Prof 
Clarke, we realised that our effort, although commendable 
and extremely useful at the early stage, was also adding to 
research waste and our time might be better spent sup-
porting others who could sustain the effort required. 
One of the key lessons we draw from the meta-evidence 
project (and hindsight afforded to us over a year after the 
pandemic started) is the importance of early and mean-
ingful stakeholder engagement when creating research pri-
orities. Stakeholder engagement was simply something we 
did not consider, and possibly may have ignored due to 
limited time and resources and the increased pressure to 
provide information, fast. 
However, Cochrane’s Question prioritization process and 
the Core Outcome Measures in Effectiveness Trials 
(COMET) initiative (9) demonstrates that engaging with 
multiple stakeholders including researchers, clinicians, pa-
tients, funders and policy makers is possible and will likely 
provide useful and meaningful research findings.  
 
Conclusions 
Combinations of evidence synthesis, information re-
trieval, and medical expertise allowed the team to care-
fully curate specific and useful RSS feeds which directly 
fed to an automated twitter bot. This was a good way 
of finding and presenting much needed evidence 
quickly and early in the pandemic at a time where ru-
mours and conjecture were spreading throughout so-
cial media and causing panic.  
We were able to recognise (through the bot and early 
mapping exercise) that there was important and poten-
tially life-saving research being produced from all cor-
ners of the world, particularly China, and we recognise 
the need to engage with researchers in China to allow 
us to effectively map and better represent the global 
evidence.   
In conclusion, the meta-evidence project was extremely 
useful in the early stages of the project as a place to 
produce, in real time, the emerging global evidence, 
and also to visually present it. The decision to halt some 
parts of the project was a pragmatic one. A decision 
that allowed us to collaborate and support those groups 
who are still working tirelessly today.   
of this research. 
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